Autres langues Harvard Bioscience, Inc.

Actions

HBIO

US4169061052

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 29/04/2024			Varia. 5j.	Varia. 1 janv.
3,71 ^USD	+2,49 %		+0,27 %	-30,65 %

09/04	Harvard Bioscience réduit ses effectifs	MT
09/04	Harvard Bioscience, Inc. annonce des mesures visant à améliorer l'efficacité opérationnelle et à soutenir les investissements en cours dans la croissance	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET	29/04
Harvard Bioscience Reducing Headcount	09/04
Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth	09/04
Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth	09/04
Harvard Bioscience, Inc. Enters into A Third Amendment to the Credit Agreement	03/04
Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti’s Small Cap Conference and KeyBanc’s Life Sciences & MedTech Conference	11/03
Harvard Bioscience: Q4 Earnings Snapshot	07/03
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 Revenue $28.2M	07/03
Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q4 EPS $0.04	07/03
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results	07/03
Harvard Bioscience Announces Fourth Quarter 2023 Financial Results	07/03
Harvard Bioscience, Inc. Provides Revenue Guidance for the Full Year 2024	07/03
Harvard Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	07/03
North American Morning Briefing : Powell Still in -2-	07/03
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting	06/03
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications At Society of Toxicology Meeting	06/03
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET	27/02
Harvard Bioscience Schedules Fourth Quarter 2023 Earnings Conference Call for March 7, 2024 at 8:00 AM ET	27/02
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023	20/11
Harvard Bioscience to Present at Benchmark Company’s Discovery One-On-One Investor Conference on December 7, 2023	20/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Harvard Bioscience, Inc.

Actions

HBIO

US4169061052

Autres langues

Filtres